Calithera Biosciences (NASDAQ:CALA) Earns Hold Rating from Analysts at StockNews.com

Stock analysts at StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research report issued to clients and investors on Sunday. The firm set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

NASDAQ CALA opened at $0.00 on Friday. Calithera Biosciences has a 12 month low of $0.00 and a 12 month high of $0.12.

About Calithera Biosciences

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.